Evidence map›Paper›PMID 36520152›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2023

Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.

Ella F Whittle, Madison Chilian, Ehsan Ghayoor Karimiani, Helga Progri, Daniela Buhas, Melis Kose, Rebecca D Ganetzky, Mehran Beiraghi Toosi, Paria Najarzadeh Torbati, Reza Shervin Badv and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. HeterozygousJIMD reports · 2026
    Article
  2. Article
  3. Case Report: Biallelic variants inFrontiers in pediatrics · 2025
    Article
  4. Article
  5. Article
  6. The alpha-ketoacid dehydrogenase complexes ofmicroPublication biology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 6 countries.

Ella F WhittleGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom.
Madison ChilianAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Ehsan Ghayoor KarimianiGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom; Innovative Medical Research Centre, Faculty of Medicine, Islamic Azad University-Mashhad Branch, Mashhad, Iran.
Helga ProgriAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Daniela BuhasDivision of Medical Genetics, Department of Specialized Medicine, McGill University Health Center, Department of Human Genetics, McGill University, Montreal, Canada.
Melis KoseDivision of Inborn Errors of Metabolism, Department of Pediatrics, Izmir Katip Çelebi University Faculty of Medicine, Izmir, Turkey; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.
Rebecca D GanetzkyMitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Mehran Beiraghi ToosiDepartment of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Paria Najarzadeh TorbatiDepartment of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad Iran.
Reza Shervin BadvChildren's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Ivan ShelihanDivision of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, Canada.
Hui YangGeneDx, Gaithersburg, MD.
Houda Zghal ElloumiGeneDx, Gaithersburg, MD.
Sukyeong LeeVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX.
Yalda JamshidiGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom.
Alan M PittmanGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom.
Erika IgnatiusDivision of Child Neurology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Shamima RahmanMitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, and Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Reza MaroofianGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom; Department of Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, United Kingdom.
Wan Hee YoonAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK. Electronic address: wanhee-yoon@omrf.org.
Christopher J CarrollGenetics Section, Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, United Kingdom. Electronic address: ccarroll@sgul.ac.uk.
St George's, University of London · GBOklahoma Medical Research Foundation · USChildren's Hospital of Philadelphia · USBaylor College of Medicine · USChildren's Medical Center · IRGreat Ormond Street Hospital for Children NHS Foundation Trust · GBMashhad University of Medical Sciences · IRMcGill University · CAMcGill University Health Centre · CAUniversity College London · GBUniversity of Helsinki · FI

Funding

Understanding connective tissue development and disease with PDGFR-driven..... P20GM103636 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2013 to 2023
$26.9M
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PennP50HD105354 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ERIC D MARSH, ROBERT Thomas SCHULTZ · 2021 to 2026
$9.2M
Role of ATAD3A in Lysosomal Homeostasis and NeurogenesisR01NS121298 · NINDS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI YOON, WAN HEE · 2021 to 2025
$2.2M
Structure, Function, and Mechanism of a Mitochondrial ChaperoneR01GM142143 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI TSAI, FRANCIS T.F. · 2021 to 2024
$2.2M
Department of HealthMedical Research Council G0601943Medical Research Council MR/N013638/1Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1NICHD NIH HHS P50 HD105354NIGMS NIH HHS P20 GM103636NIGMS NIH HHS R01 GM142143NINDS NIH HHS R01 NS121298
6 · The paper itself

Abstract

purposeThis study aimed to establish the genetic cause of a novel autosomal recessive neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.

methodsWe performed a detailed clinical characterization of 4 unrelated individuals from consanguineous families with a neurodevelopmental disorder. We used exome sequencing or targeted-exome sequencing, cosegregation, in silico protein modeling, and functional analyses of variants in HEK293 cells and Drosophila melanogaster, as well as in proband-derived fibroblast cells.

resultsIn the 4 individuals, we identified 3 novel homozygous variants in oxoglutarate dehydrogenase (OGDH) (NM_002541.3), which encodes a subunit of the tricarboxylic acid cycle enzyme α-ketoglutarate dehydrogenase. In silico homology modeling predicts that c.566C>T:p.(Pro189Leu) and c.890C>A:p.(Ser297Tyr) variants interfere with the structure and function of OGDH. Fibroblasts from individual 1 showed that the p.(Ser297Tyr) variant led to a higher degradation rate of the OGDH protein. OGDH protein with p.(Pro189Leu) or p.(Ser297Tyr) variants in HEK293 cells showed significantly lower levels than the wild-type protein. Furthermore, we showed that expression of Drosophila Ogdh (dOgdh) carrying variants homologous to p.(Pro189Leu) or p.(Ser297Tyr), failed to rescue developmental lethality caused by loss of dOgdh. SpliceAI, a variant splice predictor, predicted that the c.935G>A:p.(Arg312Lys)/p.(Phe264_Arg312del) variant impacts splicing, which was confirmed through a mini-gene assay in HEK293 cells.

conclusionWe established that biallelic variants in OGDH cause a neurodevelopmental disorder with metabolic and movement abnormalities.

Indexed as

Movement DisordersNeurodevelopmental DisordersAnimalsDrosophila melanogasterHEK293 CellsHumansKetoglutarate Dehydrogenase ComplexKetoglutarate Dehydrogenase ComplexMitochondriaNeurodevelopmental diseaseOGDHOxoglutarate dehydrogenaseα-ketoglutarate dehydrogenase deficiency

Identifiers

PMID36520152
PMCPMC9905285
OpenAlexW4311507711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.